A61K 49/14
Peptides
Official title: Peptides, e.g. proteins
A61K49/14 (Peptides) appears on 526 US grants and 732 published applications in this corpus.
Search patents in A61K- Granted patents
- 526
- Published applications
- 732
- Assignees
- 422
- Inventors
- 1,548
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 5 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 6 | 0 |
| 1995 | 9 | 0 |
| 1996 | 9 | 0 |
| 1997 | 22 | 0 |
| 1998 | 12 | 0 |
| 1999 | 12 | 0 |
| 2000 | 12 | 0 |
| 2001 | 8 | 3 |
| 2002 | 5 | 18 |
| 2003 | 11 | 27 |
| 2004 | 11 | 24 |
| 2005 | 9 | 27 |
| 2006 | 7 | 34 |
| 2007 | 11 | 23 |
| 2008 | 8 | 21 |
| 2009 | 2 | 40 |
| 2010 | 12 | 36 |
| 2011 | 16 | 38 |
| 2012 | 25 | 31 |
| 2013 | 23 | 41 |
| 2014 | 30 | 42 |
| 2015 | 24 | 38 |
| 2016 | 27 | 46 |
| 2017 | 27 | 30 |
| 2018 | 27 | 25 |
| 2019 | 20 | 33 |
| 2020 | 23 | 37 |
| 2021 | 18 | 28 |
| 2022 | 17 | 20 |
| 2023 | 13 | 19 |
| 2024 | 11 | 22 |
| 2025 | 15 | 19 |
| 2026 | 11 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Peptide libraries with non-canonical amino acids6 Oct 2026US 12,753,205 B2Regeneron Pharmaceuticals, Inc.
- Contrast agents, methods for preparing contrast agents, and methods of imaging18 Aug 2026US 12,708,677 B2Georgia State University Research Foundation, Inc.
- Combination therapy of MDNA55 and a vascular endothelial growth factor a (VEGF-A)11 Aug 2026US 12,702,710 B2Medicenna Therapeutics Inc.
- Methods for magnetic resonance imaging of nanoconstructs and uses thereof28 Jul 2026US 12,690,779 B2Kuva Labs Inc.
- Amyloid-binding compounds and methods of use thereof21 Jul 2026US 12,687,540 B2Vanderbilt University
- Anti-tslp nanobodies and their applications17 Sep 2026US 2026/0274941 A1Shanghai Novamab Biopharmaceuticals Co., Ltd.
- Human mesothelin binders3 Sep 2026US 2026/0258147 A1
- Peptide multimer products and methods27 Aug 2026US 2026/0248969 A1The Regents of the University of Michigan
- Targeted protein contrast agents, methods of making, and uses thereof30 Jul 2026US 2026/0216379 A1Georgia State University Research Foundation, Inc.
- Multi-modal molecular imaging nanoprobe for early warning and dynamic monitoring of atherosclerotic plaques and use thereof23 Apr 2026US 2026/0108636 A1The Sixth Medical Center of Chinese Pla General Hospital
Most cited
By later US patents
- Diagnostic media413US 4,647,447 ASchering Corporation · 1987
- Tumoricidal methotrexate-antibody conjugate378US 4,699,784 ACenter for Molecular Medicine and Immunology · 1987
- Antibody-metal ion complexes348US 4,741,900 ACytogen Corporation · 1988
- Diagnostic and therapeutic antibody conjugates285US 5,057,313 ACenter for Molecular Medicine and Immunology · 1991
- Compositions for targeting the vasculature of solid tumors254US 6,051,230 ABoard of Regents, The University of Texas System · 2000